Unknown

Dataset Information

0

COVID-19 vaccines elicit robust cellular immunity and clinical protection in chronic lymphocytic leukemia.

ABSTRACT:

SUBMITTER: Parry H 

PROVIDER: S-EPMC9072807 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown COVID-19 vaccination: Evaluation of humoral and cellular immunity after the booster dose in chronic lymphocytic leukemia patients.
| S-EPMC9880611 | biostudies-literature
Unknown Effects of the BTN162b2 mRNA COVID-19 vaccine in humoral and cellular immunity in patients with chronic lymphocytic leukemia.
| S-EPMC9537931 | biostudies-literature
Unknown Vaccines elicit highly conserved cellular immunity to SARS-CoV-2 Omicron.
| S-EPMC8930761 | biostudies-literature
Unknown Diminished humoral and cellular responses to SARS-CoV-2 vaccines in patients with chronic lymphocytic leukemia.
| S-EPMC9906469 | biostudies-literature
Unknown Cellular origin and pathophysiology of chronic lymphocytic leukemia.
| S-EPMC3501361 | biostudies-literature
Unknown Humoral and cellular immunogenicity of SARS-CoV-2 vaccines in chronic lymphocytic leukemia: a prospective cohort study.
| S-EPMC8789382 | biostudies-literature
Unknown Chronic Lymphocytic Leukemia-Derived IL-10 Suppresses Antitumor Immunity.
| S-EPMC6555426 | biostudies-literature
Unknown Vaccines Elicit Highly Cross-Reactive Cellular Immunity to the SARS-CoV-2 Omicron Variant.
| S-EPMC8750713 | biostudies-literature
Unknown Idelalisib impairs T-cell-mediated immunity in chronic lymphocytic leukemia.
| S-EPMC6269319 | biostudies-literature
Unknown SARS-CoV-2 specific cellular response following COVID-19 vaccination in patients with chronic lymphocytic leukemia.
| S-EPMC8693592 | biostudies-literature